chrisvoncsefalvay/vaers-outcomes huggingface dataset:
DID NOT FEEL WELL; Fever; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, batch number and expiry date were not reported) dose was not reported, administered on 09-MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On MAR-2021, the subject experienced did not feel well. On MAR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever and did not feel well was not reported. This report was non-serious. This case, from the same reporter is linked to 20210319252.
entire tongue began to itch; entientire tongue began to itch, tingle; A small bruise-like spot appeared on the tip of her tongue; This is a spontaneous report from a contactable Nurse reported for self. This 65-year-old female patient (not pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an 19Dec2020 14:30 on Arm left at single dose (Lot # EKS730) for covid-19 immunisation. Facility where the most recent COVID-19 vaccine was administered: hospital. Medical history included Gastrooesophageal reflux disease. Concomitant medications included omeprazole. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Past drug history included Allergies to medications, food, or other products: Bactrim, Ceftin. On 20Dec20200 8:30 AM, 18 hours after receiving the vaccine her entire tongue began to itch, tingle. No swelling noted. A small bruise-like spot appeared on the tip of her tongue. 5 hours later the itching stopped (20Dec2020 13:30) and the bruise-like spot began to fade. The spot was completely gone the next morning. There was no trauma to the tongue at any point that would account for the spot. Prior to vaccination, was the patient did not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No treatments were received for the events. Outcome of the event tongue itching was recovered on 20Dec2020 13:30. Outcome of the event a small bruise-like spot appeared on the tip of her tongue was recovered on 21Dec2020. Outcome of the event tingling tongue was recovered in Dec2020. Events assessed as non serious.
About 6-7 hours after the injection, there was severe pain at the injection site.  An hour later I had weakness, sweating, nausea, abdominal cramping and passed out twice.
This spontaneous report as received from an office manager refers to a 59 year old patient with cancer of prostate, hypertension and hyperlipidemia and no known drug allergies. In October 2013, about a week ago, the patient was vaccinated with ZOSTAVAX (Lot #, dose and route not provided). Concomitant therapies included LIPITOR, quinapril hydrochloride (manufacturer unknown) and hydrochlorothiazide (manufacturer unknown). Office manager stated that patient had a cystoscopy on 16-OCT-2013. On 17-OCT-2013, the patient visited office for pain and discomfort. The physician would like to prescribed MEDROL pack "steroids" to treat pain, swelling and discomfort but had not yet ordered. Last week patient underwent a physical exam which included blood work. The outcome of pain, swelling and discomfort was unknown. Additional information has been requested.
Tired; Had a temperature of 99; Small cough, not a lot, kind of a loose cough, not dry hacky cough; a little bit of light swelling at the injection site; This is a spontaneous report from a contactable consumer. A 75-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: ER9231), via an unspecified route of administration on 22Jan2021, 11:00 at a single dose for covid-19 immunization. The patient's medical history included diabetes mellitus and heart  issues from an unknown date. On 22Jan2021, the patient had a little bit of light swelling at the injection site. The patient slept good and did hot get any other symptoms. On  23Jan2020, in the afternoon, the patient had small cough, not a lot, kind of a loose cough, not dry hacky cough. On 24Jan2021, patient was tired, had a temperature of 99 in the morning. The patient did not have treatment for the events. The outcome of the events was unknown.
I have a horrible cough that escalated to a loss of appetite. My food did not taste good and I started to have a low grade fever. I also had joint aches random pain and watery eyes. The cough was so bad that I had trouble catching my breath. My right arm felt like someone was squeezing it very tight and I had backaches when that happened. By Sunday we went to the clinic and was given antibodies. I was not any better so I went to the doctor as I had already developed an earache. He gave me antibodies and penicillin. It slowly got better. The indicated that it was likely a virus. I am still having ear pain. All the others symptoms have resolved. The ear pain started prior to the other symptoms. It was at least one week prior. Both the COVID-19 and Flu Test were negative. I don't know if I am fully recovered at this time.
contracted covid in between doses; contracted covid in between doses; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a female patient of an unspecified age received first dose of BNT162B2 (Solution for injection, PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on 18Mar2021 as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date in 2021, the patient contracted COVID -19 in between doses. The patient received the second dose on 08Apr2021 and wanted to know if she needed the second dose again. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Information has been received from a physician concerning a 24-month-old female who was vaccinated with a 0.5ml dose of VERIVAX (Oka/Merck) (lot # not reported) for prevention of chicken pox. It was reported that the patient experienced shingles after vaccination. The patient sought medical attention. Subsequently, the patient recovered from shingles on an unspecified date. Additional information  been requested.
Adverse event:  LN administer 2.5mL instead of 0.25mL,  Treatment : Monitor patient for ASE,  Outcome :   V/S WNL,  No SOB.
Arm tingling and soreness first 30 minutes, then just sore. About 6 hours later, extreme chills and pain throughout body, sore joints, lightheaded, fever.
Patient has had extreme pain in her left arm since getting the vaccine. Patient spoke to me when she came in for the second vaccine. I told her it was uncommon to have a sore arm for that long after getting a shot. Told her that it may have been due to the RPh administering vaccine before it was fully diluted (still had particulate). Patient came back on 12/30/2020 to inform me that she went to PCP and they said that it was bursitis from the injection being too high in the arm. Patient said that pain has worsened and has severely impaired her QOL.
110 fever sz hospitalized 16JUL95; MD dx infect in blood & urine;
swollen lymph node (left side); swollen lymph node (left side), tender to touch, painful at this point; leg hurting; lymph node (left side), tender to touch,; very lethargic, unable to keep energy; extremely tired; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 14Apr2021 at 10:30 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included spironolactone (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication. The patient previously took penicillin for an unknown indication on an unknown date and experienced allergy. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the right arm on 24Mar2021 at 12:00 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Apr2021, the patient underwent nasal swab test and the result was negative. On 14Apr2021, the  patient experienced lethargic and tiredness. On 19Apr2021, the patient experienced swollen lymph nodes,  lymph node tenderness, lymph node pain and leg pain. Its reported that the patient was feeling unwell since she received the shot, very lethargic, unable to keep energy up during the day, extremely tired, recently a swollen lymph node (left side), tender to touch, painful at this point, as well as leg hurting for a full day. Pain medication doesn't work well either. Therapeutic measures taken for the reported events included treatment with pain medications. The clinical outcome of the events of lethargic, tiredness, swollen lymph nodes, lymph node tenderness, and lymph node pain was not recovered at the time of this report. The clinical outcome of the event of lymph node pain was recovered on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Post 15 minutes of recieiving vaccines, pt complained and had symptoms of swollen eyes and coughing. MD administered epinephrine 1:1000 0.2mg SQ, Orapred 30mg PO, and Benedryl 25mg PO.
Body shaking and chills, severe body aches, mild chest tightness, headache, nausea, and diarrhea (diarrhea started around 24 hour mark of symptom onset). Total of 4 waves of these symptoms lasting for about 26 hours total. Took Ibuprofen, Tylenol, and Zofran to help with symptoms. Medication would help with my body shaking, chills, and headache but did not completely help with body aches in joints. Woke up around 3 AM (26 hours after symptom onset) and at 9 AM feeling well but began to get body aches and a little bit of nausea again around 12 PM.
Patient presented for loss of vision in right eye. Was previously seen for in ER for this same incident in 8/2021 and referred to ophthalmology. During this stay, patient diagnosed with central retinal artery occlusion. Hospital stay 11/2-11/4/2021 (2 days) under "observation status."
I21.4 ACUTE NON ST ELEVATION MI 2/8/2023 ACUTE NON ST ELEVATION MI I21.4 ACUTE NON ST ELEVATION MI 2/8/2023 CAD (CORONARY ARTERY DISEASE) WO ANGINA
My body odor has changed as well as my smell and taste is now really off. Most food and  drinks  I can?t tolerate due to the smell or taste.  My bowel smells different really weird smelling now
Head shaking, approximately every 5 minutes lasting hours at a time. Mother stated, "it looks as if he is trying to shake off a bug". Mother also reports that patient stated something inside his brain is making him want to shake his head.
extremely tired; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 21Feb2021 10:30 (Lot number: EL9266) at the age of 57 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Known allergies: environmental" (unspecified if ongoing). The patient took concomitant medications. The following information was reported: FATIGUE (non-serious) with onset 24Feb2021, outcome "recovered" (25Feb2021), described as "extremely tired". The event "extremely tired" was evaluated at the physician office visit. Therapeutic measures were not taken as a result of fatigue.  Additional information: Facility type vaccine was other. No other vaccine in four weeks. Other medications in two weeks. After first dose extremely tired on day 3. Was fine the next day. After second dose: very sore arm for less than 24 hours, a few days later developed pimples/hives inside of mouth and had a very red throat, non-painful throat. Pimple come and go, 4 Weeks later woke up to hives all over my torso along with the pimples in mouth. Hive went away after about a week. Redness in throat is at a minimum now, but still getting a smaller pimple almost every day. Saw ENT and Dentist about throat not linking the possible connection to the vaccine. Both felt there was nothing serious to be concerned with. Ae resulted in doctor or other healthcare professional office/clinic visit. No treatment for AE. No covid prior vaccination. Not tested for covid post vaccination. Known allergies were environmental.  No follow-up attempts are possible. No further information is expected.
Body aches all over, sore & dry throat, rhinitis. Felt better after 2 wks.
Patient received the Pfizer Vaccine at 9:10 am at vaccination site then sat at the observation area for 15 min. for monitoring. Nurse was flagged down by observation staff stating patient c/o dizziness 15 mins after administration of vaccine. RN offered patient to laydown. patient refused stating only slightly dizzy. patient drank water, ate a candy bar, RN took VS and noted to be stable. Patient was monitored for 30 mins before departure. VS stable prior to departure.  Patients father  drove after appointment and RN instructed patient and family on Symptoms of Severe Adverse Reactions to report to health care provider or to go to the emergency room. Patient verbalized understanding.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 14Dec2021 at 10:15 as dose 4 (booster), single (Lot number: FD0809) at the age of 47 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. The patient had no known allergies. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of suspected covid-19 which included paxlovid from 02Jun2022 to 05Jun2022.  No follow-up attempts are possible. No further information is expected.
slightly itchy rash that developed on b/l arms, R side of face and on neck noticed with progression the following morning. Rash appears to be maculopapular; Some itching and irritation noted. No cp, f, n/v, angioedema, sob, dizziness, joint pain, urinary symptoms or abdominal pain
Rash to trunk & neck - mac/pap - treated with BENADRYL skin care mild soaps filed -> per doctor.
Patient received dose from  refrigerator with an issue; This case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a 62-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number B4C44, expiry date 10th November 2024) for prophylaxis.   Co-suspect products included dtpa vaccine. pre-filled syringe device (Boostrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 6th February 2023, the patient received Boostrix (intramuscular) and Boostrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Boostrix and Boostrix Pre-Filled Syringe Device, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 10-FEB-2023 Reporter's Comment: The reporter consented to follow up. Additional supportive information: The patient received a Boostrixin left arm, taken from medical refrigerators and discovered that the refrigerators had an issue, which led to incorrect storage of drug.
Patient reported  the following on a call  of 03/07/2022, that she presented hives on the whole body accompanied with itichiness form  the neck down, for four days since - 02/24/22 to 02/28/22-, also report hives accompnied with itchiness on the injection site, did not reported other symptoms as trouble to breathing, tireness or dizziness or swelling, did not took any medication, but use regular body lotion to help to calm the itchiness, neither consulted to the doctor or went to the ER. On the call of 03/07/2022 reported feeling good all and the symptoms diseapeared by then.
pt recv vax; er visit 25jun; parotitis;mom noticed swelling at 9:30am 25jun95;
pt got cellulitis in arm after given shot.  pt went to doctor to have it checked out. was given keflex for the infection. keflex was filled. pt still recovering
Experienced body aches, fatigue, scratchy throat.  No treatment.  After going back to bed that morning and sleeping  for approximately 2  hours symptoms started to relieve themselves
Erythema that is blanchable on Right upper arm extending 19cm (high) by 13cm width, arm Circ. 23cm vs left arm 19cm warm to touch, painful on palpation, has full ROM at farm, for 24 hours. Treatment: allergy medication. Recovery: unknown.
Within 12 hours I was bedridden for three (3) straight days.  I experienced continued fatigue that worsened over time resulting in sleeping half the day and not able to perform basic physical exercise like walking over 1 mile.  Prior to the vaccination I was able to hike 10 miles in a day.  Then on 08/02 I was admitted to the emergency room with severe chest pains and awaiting further test results.
Slight headache; Sore arm; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP).  A female patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "Slight headache"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "Sore arm".  Additional information: Woman experienced slight headache and sore arm the day after receiving the Pfizer COVID vaccine. Event took place after use of product.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Rash on upper arm occurred 1 hour after injection,. Removed bandaid. Hydrocortisone applied and referred to MD.
No additional adverse event; PNEUMOVAX 23 was administered to the patient after the excursion occured/ temperature 0.3C for 24 hours; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On 13-APR-2022, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, lot #U021995, expiration date: 13-JAN-2023, administered for prophylaxis (strength, and route of administration were not provided).   It was reported that on that day, pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was administered to the patient after the excursion occurred. Administered dose of vaccine experienced the temperature excursion of 0.3 degrees Celsius for 24 hours (product storage error). Previous temperature excursion was reported as yes.  No additional adverse event of product quality complaint were reported.
pt returned to office 5min p/vax c/o SOB, diff breathing, throat pain & rash;adrenalin given; wm in later breathing better but wheezing;nebulizer therapy given about 15min later lungs cleared;given meds & pt better;
Have been diagnosed with Polymyalgia Rheumatica with various muscle pains and limitation of movement. Started on long term oral Prednisone
Severe left shoulder pain radiating into left neck/supraclavicular; associated swelling; eval by Dr. on 11/18/2015 and steroids initiated.
Mom reports that fever started within 5 hours of flu shot. Inappropriate laughter in the night-fever 102 and "was out of it". In office visit, day after Flu shot, he reports abd. pain, and mild headache. Denies sore throat, denies vomit/diarrhea no cough, no rash. C/O being tired, taking sips of fluids.
Report 2002001621-1 describes sore arms in a 65 year old female who received hepatitis B vaccine recombinant (Engerix B). Concurrent medical conditions included menopause and Barrett's esophagus (starting in 1999) which was treated with omeprazole. On 1/18/02, the vaccinee received her third dose of Engerix B. She received two injections of the 10mcg pediatric formulation (lot ENG5252A2; expiry 4/10/03), to provide the adult dose of 20 mcg. On that date, she also received her second injection of hepatitis A vaccine inactivataed. On 1/20/02, she experienced tiredness, sore arms, and generalized myalgias. Medical attention at the clinic was required. The vaccinee was treated with acetaminophen. The vaccinee did not have the same side effects with previous doses. The reporter stated that the events were mild in intensity, and possibly related to Engerix B. As of 2/25/02, the events had resolved.
Gave Menactra first in right arm, then HPV in left arm.  While giving HPV, Patient fainted.  She was sitting in armed,high back chair. Her head dropped to the side for a few seconds, then she came to.  Was very hot, sweaty, and weak.  Gave her cold water and a granola bar.  She then stated to her mom that she had only eaten an orange for lunch and it was now 6:30pm.  She stayed sitting in the pharmacy for over 30 minutes until she felt stronger.  I spoke with the mom 08/06/2019 and she said Patient experienced no other side effects and felt better after eating and getting a good night's sleep.
This spontaneous report as received from a pharmacist refers to a 65 year old female patient. Pertinent medical history was none. On 23-APR-2013, the patient was vaccinated with ZOSTAVAX (Lot # J000435, expiry date was 10-APR-2014), 0.65 milliliter (ml), subcutaneously. No concomitant medications were taken. Approximately on an unknown date in April 2013 (reported as now), the patient experienced inflammation and redness at the injection site. Diagnostic test performed was none. The patient sought medical attention (called the pharmacy) and no treatment was provided. The outcome of inflammation and redness at the injection site was reported as not recovered/not resolved. Additional information has been requested.